Knights of Columbus Asset Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-12,027
Closed -$834K 404
2024
Q2
$834K Hold
12,027
0.05% 273
2024
Q1
$963K Sell
12,027
-33,823
-74% -$3.01M 0.07% 246
2023
Q4
$5.02M Buy
45,850
+27,060
+144% +$2.8M 0.32% 124
2023
Q3
$1.89M Buy
18,790
+485
+3% +$55.7K 0.17% 183
2023
Q2
$2.49M Buy
18,305
+40
+0.2% +$4.88K 0.22% 142
2023
Q1
$1.9M Buy
18,265
+77
+0.4% +$7.45K 0.19% 184
2022
Q4
$1.61M Sell
18,188
-209
-1% -$17.3K 0.17% 202
2022
Q3
$1.48M Buy
18,397
+2,171
+13% +$205K 0.15% 197
2022
Q2
$1.55M Buy
16,226
+170
+1% +$20.4K 0.16% 183
2022
Q1
$2.38M Sell
16,056
-4,858
-23% -$678K 0.2% 163
2021
Q4
$2.96M Buy
20,914
+373
+2% +$52.8K 0.24% 132
2021
Q3
$2.69M Buy
20,541
+109
+0.5% +$14.3K 0.24% 134
2021
Q2
$2.81M Buy
20,432
+158
+0.8% +$21.6K 0.26% 131
2021
Q1
$2.65M Sell
20,274
-270
-1% -$32.5K 0.26% 129
2020
Q4
$2.3M Buy
20,544
+3,141
+18% +$297K 0.24% 149
2020
Q3
$1.37M Sell
17,403
-2,571
-13% -$210K 0.17% 198
2020
Q2
$1.44M Buy
+19,974
New +$1.39M 0.18% 181

Other funds holding CNMD

Knights of Columbus Asset Advisors's CNMD Position: Q3 2024 in Review

Knights of Columbus Asset Advisors sold out of CONMED (CNMD) in Q3 2024, closing a stake of 12,027 shares — an estimated $834K sold.

Knights of Columbus Asset Advisors first reported a position in CNMD in Q2 2020 and held it in 17 quarters. The position peaked at $5.02M in Q4 2023. 290 funds tracked by Wall St. Rank hold CNMD as of Q3 2024.

  • Knights of Columbus Asset Advisors reported no remaining CONMED position as of Q3 2024 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 12,027 CONMED shares in Q3 2024, an estimated $834K.
  • Knights of Columbus Asset Advisors first reported a position in CONMED in Q2 2020 and held it in 17 quarters.
  • Knights of Columbus Asset Advisors's CONMED position peaked at $5.02M in Q4 2023.
  • 290 funds tracked by Wall St. Rank held CONMED as of Q3 2024.

Based on Knights of Columbus Asset Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.